Non-Accredited Education
Understanding Collagen Dressings and their Benefit in Wound Care Complimentary Archived Webcast
Non-Accredited
Issue
- Issue:8
Aberrant wound healing is a significant problem that affects millions of patients yearly. Keloids, for example, are characterized by the formation of exuberant, firm scar tissue that does not flatten over time.
- Issue:8
Acknowledgments: Mr. Soldevilla is the Director of the Grupo Nacional para el Estudio y Asesoramiento en Úlceras por Presión y Heridas Crónicas (GNEAUPP; the national pressure ulcer and chronic wound advisory panel); Mr. Torra is the former Deputy Director of the GNEAUPP; and Dr. Verdu, Mr. Rueda, and Mr. Martinez are members of the GNEAUPP steering committee.
- Issue:8
Wound healing, a complex process, can be divided schematically into 4 phases in acute wounds, including hemostasis, inflammation, proliferation, and remodeling.1 In chronic, hard-to-heal wounds, the healing process is disrupted by several general and local causes (eg, tissue senescence, infection, underlying vascular disease, hypoxia, anemia, diabetes and other metabolic disorders, drugs),2–7 and the wound can remain in the inflammatory phase.8–13 When this occurs, the wound will be characterized by necrotic tissue or fibrin slough with tissue lo
- Issue:8
Pain, infections, and ulcerations that will not heal are common complications in patients with severe peripheral vascular disease. If the vascular stenosis or occlusion can be dilated or bypassed, these symptoms often disappear. However, if the arteries cannot be dilated or bypassed, treatments must be medical. Few drugs are available for this use, and often, antiplatelet medications are prescribed to improve circulation and prevent clotting. These drugs may produce various bleeding complications and are variably effective.1,2
- Issue:8
Coloplast Introduces SeaSorb®-Ag Alginate Dressing
Coloplast Corp. (Marietta, Ga) introduces SeaSorb®-Ag Alginate Dressing with Silver. SeaSorb-Ag is identical to SeaSorb Soft alginate dressing only it has the added antimicrobial benefit of silver.
- Issue:8
Accuzyme and Panafil Spray Emulsions Awarded “Ease-of-Use” Commendation
Healthpoint (Fort Worth, Tex) announces the launch of a new spray emulsion (SE) delivery form for ACCUZYME® (papain, urea) and PANAFIL® (papain, urea, chlorophyllin copper complex sodium). In conjunction with the launch, the Arthritis Foundation awarded the products its “Ease-of-Use” Commendation, recognizing the new delivery form with its user-friendly design. The products are the first wound care treatments to receive this commendation.
Press Release
ConvaTec and Boehringer Technologies Announce License Agreement
ConvaTec Acquires Exclusive Worldwide Rights for a Negative Pressure Wound Therapy System
SKILLMAN, NJ (December 18, 2008) — ConvaTec, a world-leading developer and marketer of innovative medical technologies for community and hospital care, announced today it has signed a long-term global exclusive license agreement with Boehringer Technologies to market and distribute Boehringer’s Engenex® Negative Pressure Wound Therapy (NPWT) System incorporating Bio-Dome™ Interface Technology.
WOUNDS News Wire
- Friday, December 5, 2008 - 15:08
- Wednesday, October 22, 2008 - 15:28
- Wednesday, October 22, 2008 - 15:25
CME Showcase
"Diabetic Peripheral Neuropathy"
Upcoming Accredited Webcast Release Date: December 22, 2008 Expiration Date: December 22, 2009 This activity is supported by an educational grant from PamLabs. To register for this Webcast, visit www.naccme.com/program/n-558/ |
"Current Concepts In Healing Chronic Diabetic Foot Ulcerations"
Upcoming Live Accredited Webcast with Q&A Noon to 1 p.m. EDT January 20, 2009 Rebroadcasts 7:30-8:30 p.m. EDT 3-4 p.m. EDT This activity is supported by an educational grant from Advanced Biohealing. To register for this Webcast, visit www.naccme.com/program/n-550/ |
| MRSA And Diabetic Foot Wounds: Where Do We Go From Here? Accredited Webcast Archive Version available now. This activity is supported by an educational grant from Pfizer. This activity is sponsored by the North American Center For Continuing Medical Education (NACCME). |
|
PERIPHERAL ARTERIAL DISEASE (PAD) AND CRITICAL LIMB ISCHEMIA (CLI): Managing Vascular and Wound Healing Challenges with Current and Emerging Technologies Maintenance Debridement: A New Look at Science and Art Accredited Webcast with Q&A: November 17, 2008 at 3:00pm EST This activity is supported by an educational grant from HealthPoint Ltd. |
REVIEW OUR OTHER
WOUND CARE BRANDS
Check out our other resources for healthcare professionals of all specialties.
